First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin - Related Studies

First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin (SQUIRE)

This study is ongoing, but not recruiting participants.

Study NCT00981058 Information provided by ImClone LLC

First Received on September 18, 2009. Last Updated on May 3, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

necitumumab
gemcitabine
cisplatin

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial